ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16.
Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25.
Popular Inc (BPOP) Concerns bank could fail.
Douglas A. McIntyre
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.